Clinical predictors of drug response in obsessive-compulsive disorder.
about
Drug treatment of obsessive-compulsive disorderExcluding the typical patient: thirty years of pharmacotherapy efficacy trials for obsessive-compulsive disorderObsessive-Compulsive Disorder, 5-HTTLPR polymorphism and treatment response.Resting-state functional connectivity between right anterior insula and right orbital frontal cortex correlate with insight level in obsessive-compulsive disorder.Dimensional correlates of poor insight in obsessive-compulsive disorder.Paroxetine treatment of compulsive hoardingCorrelates of insight among youth with obsessive-compulsive disorder.A systematic review: antipsychotic augmentation with treatment refractory obsessive-compulsive disorder.Venlafaxine extended-release treatment of hoarding disorder.Waitlist-controlled trial of cognitive behavior therapy for hoarding disorder.Meta-analysis: hoarding symptoms associated with poor treatment outcome in obsessive-compulsive disorder.Clinical treatment of obsessive compulsive disorderObsessive-compulsive disorder phenotypes: implications for genetic studies.Minocycline combination therapy with fluvoxamine in moderate-to-severe obsessive-compulsive disorder: A placebo-controlled, double-blind, randomized trial.Current management of obsessive and phobic states.Obsessive compulsive disorder masquerading as psychosis.Clinical predictors of drug response in patients with obsessive-compulsive disorderIntravenous Clomipramine for Treatment-Resistant Obsessive-Compulsive Disorder.Symptom subtypes of obsessive-compulsive disorder: are they relevant for treatment?Exposure and response prevention helps adults with obsessive-compulsive disorder who do not respond to pharmacological augmentation strategies.Treatment strategies for obsessive-compulsive disorder.Treatment of hoarding.A systematic review of the literature about competence and poor insight.Emerging drugs to treat obsessive-compulsive disorder.Psychopharmacological treatment differences in autogenous and reactive obsessions: A retrospective chart review.Dissecting the Yale-Brown Obsessive-Compulsive Scale severity scale to understand the routes for symptomatic improvement in obsessive-compulsive disorder.Predictors of response to serotonin reuptake inhibitors in obsessive-compulsive disorder.Altered cognitive response to serotonin challenge as a candidate endophenotype for obsessive-compulsive disorder.[Resistance and refractoriness in obsessive-compulsive disorder].Exploratory factor analysis of obsessive-compulsive patients and association with 5-HTTLPR polymorphism.The use of psychotropic agents for the symptoms of obsessive-compulsive disorder.Reasoning bias and belief conviction in obsessive-compulsive disorder and delusions: jumping to conclusions across disorders?Neuropsychological correlates of insight in obsessive-compulsive disorder.Sexual obsessions in pediatric obsessive-compulsive disorder: clinical characteristics and treatment outcomes.Successful treatment for obsessive-compulsive disorder with addition of low-dose risperidone to fluvoxamine: implications for plasma levels of catecholamine metabolites and serum brain-derived neurotrophic factor levels.The future of pharmacotherapy for obsessive-compulsive disorder may lie in a better understanding of its heterogeneity.Functions of compulsions in obsessive-compulsive disorder.Differences in duration of untreated illness, duration, and severity of illness among clinical phenotypes of obsessive-compulsive disorder.The impact of comorbid body dysmorphic disorder on the response to sequential pharmacological trials for obsessive-compulsive disorder.Duration of untreated illness as a predictor of treatment response and remission in obsessive-compulsive disorder.
P2860
Q24635508-3D9170DB-7046-40F0-AC8B-1F24C9B8FEE2Q27025821-BAC7E0C4-4D07-44A2-9904-5D390944319BQ33183862-025ACD64-3115-499E-8E7C-50E03F775936Q33581596-1B20E06C-28B4-49B4-8D16-C36C8F020CC3Q33724433-C2923961-6920-4F59-9A66-C66E01E5AB6BQ33875407-8C3421BE-7163-46DB-B0E7-268CDFF47989Q33897061-AC0F4CFA-32DE-441D-9C96-C905B359A47CQ33994634-087A9861-C7D5-47F3-A87A-784A0C8A5B70Q34005759-F150E34D-0AFD-4BB2-ABE7-0E072A6EF657Q34021821-E73F2493-EF63-463C-8FDF-A3DFBB469225Q34216780-2F2E22BC-150D-42DB-B7ED-130C85417FEEQ34359796-DFC15BA1-D432-4210-8A40-E69C38F1D8C9Q34378597-C014F017-91E9-441B-BD68-8414DA754B3BQ34678136-CE46356B-83BF-42A4-8F21-213903EAD82FQ35327098-29DB3A0D-5168-40FA-AFFF-DD1F93F61F4AQ36401024-8B78CBEC-0B3D-4AB9-8500-5D84AA305064Q36599213-860551C2-B00C-4256-A0F3-7B2B575DB936Q36635618-9E4F1215-24D4-4986-BE5E-81F7DFEC01B9Q37214734-8306337D-191F-4C60-A2C5-8D3A31549C3EQ37468737-26E5DAB5-9C7D-4244-BB68-F0B8274AA0C2Q37681560-99BDEFD5-720D-4FB4-B624-5BE7C2A39532Q37688077-38E9B07C-3E4B-4A6E-80E4-4162DDA3CE9DQ37929274-999EEE8C-6302-4063-8965-66CF57773310Q38174649-43C95A6D-7D5E-469A-9FBB-EDBAC9A459EDQ38465299-09BA8DA3-C13B-4307-B5D2-6E9BE1F48AB5Q38820484-C324333A-94A2-4CBA-A5A9-D96833D514EEQ38860324-26363170-E2BE-49C4-9E83-30B6F4BDF034Q38934428-0CE56A33-3BCB-411E-8D3F-5D3BEF7E7727Q39325451-6108C01E-43B9-4072-8B23-DC350D3F1746Q43938287-A699E108-9559-4BD7-BA78-396D6A036E0EQ44267898-57DC4F5F-3AB5-4874-AFDF-DCB0928D838BQ47231982-67A58EC9-4923-4826-8B4C-D46C96D0DC21Q48005720-F59AB3DC-DE3B-43C9-84B9-5FF90539FFCCQ48035062-4B492607-BA01-4F3D-98FA-85A6856155F8Q48518653-206294B9-9E4C-4C60-BA55-64A042BF20D4Q48910067-547DE892-F32E-44A8-9DA5-7B2EDCEBD750Q50632260-3B3E42B2-0894-46F1-A654-A51241326BD4Q50636036-A3A07A43-00A1-45AF-8628-66121A767B5BQ51137800-5E029194-213D-42DE-B10A-3BE3F4438832Q51859310-546114AA-C947-4137-A32E-257E59C7238A
P2860
Clinical predictors of drug response in obsessive-compulsive disorder.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
Clinical predictors of drug response in obsessive-compulsive disorder.
@en
Clinical predictors of drug response in obsessive-compulsive disorder.
@nl
type
label
Clinical predictors of drug response in obsessive-compulsive disorder.
@en
Clinical predictors of drug response in obsessive-compulsive disorder.
@nl
prefLabel
Clinical predictors of drug response in obsessive-compulsive disorder.
@en
Clinical predictors of drug response in obsessive-compulsive disorder.
@nl
P2093
P1476
Clinical predictors of drug response in obsessive-compulsive disorder
@en
P2093
G Diaferia
M Locatelli
P Cavedini
P304
P356
10.1097/00004714-200110000-00006
P407
P577
2001-10-01T00:00:00Z